Jaguar Health Inc (JAGX)

Apr 06, 2025

Jaguar Health's Italian Subsidiary Napo EU Appoints Annabella Amatulli Chief Regulatory Officer - ACCESS Newswire

Apr 06, 2025

Apr 04, 2025

Jaguar Animal Health Secures $3.448M in Private Placement - TipRanks

Apr 04, 2025

Apr 04, 2025

Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials - ACCESS Newswire

Apr 04, 2025

Apr 04, 2025

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ACCESS Newswire

Apr 04, 2025

Apr 04, 2025

Jaguar Health Expands Workforce: New Stock Grants Signal Growth Strategy - Stock Titan

Apr 04, 2025

Apr 04, 2025

Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4) - ACCESS Newswire

Apr 04, 2025

Apr 03, 2025

Jaguar Health outlines key Q2 2025 catalysts for crofelemer programs - MSN

Apr 03, 2025

Apr 03, 2025

Jaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product - ACCESS Newswire

Apr 03, 2025

Apr 02, 2025

Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates - ACCESS Newswire

Apr 02, 2025

Apr 01, 2025

Jaguar Health completes $3.4 million private placement By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Jaguar Health completes $3.4 million private placement - Investing.com India

Apr 01, 2025

Apr 01, 2025

Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire

Apr 01, 2025

Apr 01, 2025

Jaguar Health CEO Leads $3.4M Strategic Investment Ahead of Key 2025 Catalysts - Stock Titan

Apr 01, 2025

Apr 01, 2025

Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025

Apr 01, 2025

Jaguar Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2025

Apr 01, 2025

Jaguar Health Advances Plant-Based Pharmaceuticals - TipRanks

Apr 01, 2025

Mar 31, 2025

Jaguar Health’s Earnings Call: Growth Amid Challenges - TipRanks

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Jaguar Health sees revenue growth in Q4 2024 - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

JAGX stock plunges to 52-week low, touches $4.9 amid steep decline By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

JAGX stock plunges to 52-week low, touches $4.9 amid steep decline - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Jaguar Health sees revenue growth in Q4 2024 By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023 - ACCESS Newswire

Mar 31, 2025

Mar 31, 2025

Jaguar Health, Inc. SEC 10-K Report - TradingView

Mar 31, 2025

Mar 28, 2025

StockNews.com Begins Coverage on Jaguar Health (NASDAQ:JAGX) - Defense World

Mar 28, 2025

Mar 28, 2025

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey - Weatherford Democrat

Mar 28, 2025

Mar 27, 2025

Jaguar Health at Emerging Growth Virtual Conference: Strategic Catalysts Ahead - Investing.com

Mar 27, 2025

Mar 27, 2025

Jaguar Health CEO, board members and investors invest in $3.448M bridge financing - MSN

Mar 27, 2025

Mar 27, 2025

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study - ACCESS Newswire

Mar 27, 2025

Mar 27, 2025

Mytesi Shows Promising Results in Breast Cancer: FDA to Review Game-Changing Phase 3 Data - Stock Titan

Mar 27, 2025

Mar 26, 2025

Jaguar Health secures $3.448 million in convertible notes By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Sector Update: Health Care - MarketScreener

Mar 26, 2025

Mar 26, 2025

Jaguar Health secures $3.448 million in convertible notes - Investing.com

Mar 26, 2025

Mar 26, 2025

Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts - Corsicana Daily Sun

Mar 26, 2025

Mar 26, 2025

Jaguar Health Executives Invest in $3.5 Million Bridge Financing; Shares Fall - MarketScreener

Mar 26, 2025

Mar 26, 2025

Jaguar Health Management Backs Company with Personal Investment in $3.4M Financing Deal - Stock Titan

Mar 26, 2025

Mar 24, 2025

Upcoming Stock Splits This Week (March 24 to March 28) – Stay Invested - The Globe and Mail

Mar 24, 2025

Mar 21, 2025

JAGX stock touches 52-week low at $0.21 amid sharp annual decline - Investing.com Australia

Mar 21, 2025

Mar 21, 2025

JAGX stock touches 52-week low at $0.21 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 20, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 20, 2025

Mar 20, 2025

Jaguar Health (NASDAQ:JAGX) Now Covered by StockNews.com - Defense World

Mar 20, 2025

Mar 18, 2025

Jaguar Health initiates reverse stock split to meet Nasdaq standards By Investing.com - Investing.com Canada

Mar 18, 2025

Mar 18, 2025

Jaguar Health falls as it announces reverse stock split - MSN

Mar 18, 2025

Mar 18, 2025

Jaguar Health to Implement 1-for-25 Reverse Stock Split -March 18, 2025 at 09:05 am EDT - Marketscreener.com

Mar 18, 2025

Mar 18, 2025

Jaguar Animal Health Announces Reverse Stock Split - TipRanks

Mar 18, 2025

Mar 18, 2025

Jaguar Health initiates reverse stock split to meet Nasdaq standards - Investing.com

Mar 18, 2025

Mar 18, 2025

Jaguar Health, Inc. Announces Reverse Stock Split - ACCESS Newswire

Mar 18, 2025

Mar 18, 2025

Jaguar Health's Major 1:25 Reverse Split: Critical Move for Nasdaq Compliance - StockTitan

Mar 18, 2025